What's Happening?
Cleveland Clinic has partnered with Dyania Health to enhance its clinical trial recruitment process through AI technology. The Synapsis AI platform will be used to identify eligible patients for trials by analyzing medical records across the clinic's extensive network. This AI-driven approach aims to overcome the inefficiencies of manual chart reviews, which are time-consuming and limited in scope. The partnership is expected to improve the accuracy and speed of patient identification, thereby increasing the diversity and representation in clinical trials.
AD
Why It's Important?
The use of AI in clinical trial recruitment is a significant step forward in medical research, addressing the challenges of patient identification and enrollment. By leveraging AI, Cleveland Clinic can streamline the recruitment process, potentially leading to more successful trials and faster development of new treatments. This approach also enhances the diversity of trial participants, as AI can identify eligible patients across various locations, including community clinics that are often overlooked.
What's Next?
The Synapsis AI platform will be rolled out in phases, starting with specific disciplines and expanding to others. As the technology is adopted more widely, it could set a precedent for other medical institutions to follow, potentially transforming the landscape of clinical trial recruitment and research.
